- Home
- PROK vs ATLN Comparison
PROK vs ATLN Comparison
Compare PROK & ATLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ATLN
- Stock Information
- Founded
- PROK 2015
- ATLN 2014
- Country
- PROK United States
- ATLN United States
- Employees
- PROK N/A
- ATLN N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ATLN
- Sector
- PROK Health Care
- ATLN
- Exchange
- PROK Nasdaq
- ATLN NYSE
- Market Cap
- PROK 126.8M
- ATLN 137.6M
- IPO Year
- PROK N/A
- ATLN 2021
- Fundamental
- Price
- PROK $1.02
- ATLN $4.04
- Analyst Decision
- PROK Buy
- ATLN
- Analyst Count
- PROK 4
- ATLN 0
- Target Price
- PROK $5.00
- ATLN N/A
- AVG Volume (30 Days)
- PROK 1.3M
- ATLN 29.2K
- Earning Date
- PROK 05-09-2025
- ATLN 01-01-0001
- Dividend Yield
- PROK N/A
- ATLN N/A
- EPS Growth
- PROK N/A
- ATLN N/A
- EPS
- PROK N/A
- ATLN N/A
- Revenue
- PROK $76,000.00
- ATLN $442,609,814.00
- Revenue This Year
- PROK N/A
- ATLN N/A
- Revenue Next Year
- PROK N/A
- ATLN N/A
- P/E Ratio
- PROK N/A
- ATLN N/A
- Revenue Growth
- PROK N/A
- ATLN 10.27
- 52 Week Low
- PROK $0.46
- ATLN $1.30
- 52 Week High
- PROK $4.44
- ATLN $8.98
- Technical
- Relative Strength Index (RSI)
- PROK 60.91
- ATLN N/A
- Support Level
- PROK $0.66
- ATLN N/A
- Resistance Level
- PROK $0.89
- ATLN N/A
- Average True Range (ATR)
- PROK 0.17
- ATLN 0.00
- MACD
- PROK 0.06
- ATLN 0.00
- Stochastic Oscillator
- PROK 77.78
- ATLN 0.00
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.